https://www.medlegal360.com/januvia-lawsuits/
As modern medicine has progressed, several medications have been found to have harmful side effects and cause catastrophic harm. Even in rare instances, the severity of the damages is too great to ignore, even though the causes of these side effects vary from person to person. People with Type 2 diabetes have been exposed to various medications meant to support and affect insulin and blood sugar levels; however, some of these medications' side effects have proved harmful and occasionally fatal.
One such medication is Januvia, a diabetes treatment made by Merck that has been in use for more than ten years. Still, after a few years of being widely used, a connection between the medication and pancreatic disorders, among other issues, was discovered.
Those who suffered from the side effects filed many Januvia lawsuits against Merck & Co. In courts around the country, allegations that the medicine manufacturers failed to warn about the risk were made. Because Merck & Co. knew or should have known that Januvia may cause this lethal form of cancer, the plaintiffs in the Januvia lawsuits are suing the pharmaceutical company for payment of their medical bills, funeral expenses, and other damages.
Federal health officials claim that some batches of the diabetes drug Januvia contain nitrosamine. This carcinogen has lately led to the recall of Zantac, metformin, valsartan, and numerous other pharmaceuticals.
The makers of Zantac and Valsartan are being sued for providing tainted medications after hundreds of former users of these recalled prescriptions received cancer diagnoses. The Food and Drug Administration (FDA) issued a public safety statement on August 9, 2022, informing the public that a nitrosamine known as NTTP was found in sitagliptin medications.
You will need to prove that your damages are significant in order to be awarded a fair settlement for your injury. In that, you need the best medical record review company's help. LezDo techmed helps to review your medical records, which is helpful for your case.
No class action complaint has yet been filed in the Januvia litigation. These Januvia complaints were consolidated in 2013 by the U.S. Judicial Panel on Multidistrict Litigation in a federal court in California.
As of February 2014, 306 lawsuits related to pancreatic cancer had been brought against the makers of Januvia and similar drugs. For allegedly causing pancreatic cancer, Januvia is being sued.
The plaintiff's attorneys' claims were dismissed by a federal court judge in 2015 because, in his view, there was insufficient scientific proof linking these diabetic drugs to pancreatic cancer. But an appeals court reinstated them.
There were 948 unresolved cases in the reopened MDL as of September 17, 2018. Four hundred sixty-nine cases remained unresolved as of October 2022. You can read more blogs like lorcaserin Belviq lawsuits, Zostavax lawsuits, Tasigna lawsuits , and knee replacement lawsuits from medlegal360.
0
